Pierre Close receives an award of the Worldwide Cancer Research


Pierre Close and his team are studying how melanoma tumours resist treatment. Unravelling how melanoma cells control the way proteins are made inside the cell could reveal new ways to treat the disease.


Melanoma is the most aggressive form of skin cancer. It can often be treated easily with surgery if caught early, however once it has spread it is very aggressive. The treatments available for advanced melanoma sometimes do not work because the melanoma resists treatment. This means some patients have no other options if their cancer does not respond.

Pierre Close and his team hope to find a way to make melanoma treatments more effective by finding out how it resists attempts to treat it. They believe melanoma cells may gain the ability to control how proteins are generated in the cell, and the result of this could be what helps them to adapt, spread, and resist treatments. Uncovering how melanoma cells do this could reveal new weak spots and new ways to treat melanoma.

The Worldwide Cancer Research is funding the project for £155,000 over 2 years.

The Worldwide Cancer Research

Any new lifesaving test or treatment for cancer starts with discovery research. That's why they only fund pioneering discovery research - from anywhere in the world, into any cancer. They back brand new ideas from world-class scientists that could change the course of cancer research. Since 1979 they have been dedicated to funding the brightest researchers to start cancer cures that will save lives now, and for generations to come. They have supported £200 million of cancer research around the world. 

More information

Share this news